Navigation Links
Researchers find hepatitis A and hepatitis C attack same protein to block immune defenses

Despite the fact that they both infect the liver, the hepatitis A and hepatitis C viruses actually have very little in common. The two are far apart genetically, are transmitted differently, and produce very different diseases. Hepatitis A spreads through the consumption of fecal particles from an infected person (in pollution-contaminated food or water, for example), but hepatitis C is generally transmitted only by direct contact with infected blood. Hepatitis A produces fever, nausea and abdominal pain that can last for weeks, but rarely lead to death; hepatitis C, by contrast, often spends decades quietly damaging the liver, until a victim’s only hope for survival is an organ transplant.

According to researchers at the University of Texas Medical Branch at Galveston (UTMB), though, these two otherwise unrelated liver viruses have one important thing in common: a trick for avoiding destruction by the immune system. Both dodge immune attacks by attacking the same protein ?an essential link in a chain of molecular signals that triggers antiviral responses.

"With 30,000-plus proteins in the cell, it’s really remarkable that these two very different viruses have chosen to strike at the same one," said Dr. Stanley Lemon, director of UTMB’s Institute for Human Infections and Immunity and National Institutes of Health-funded Hepatitis C Research Center. Lemon is senior author of a paper on the research appearing online this week in the Proceedings of the National Academy of Sciences. "This identifies the protein ?called MAVS, for mitochondrial antiviral signaling protein ?as extremely important for the survival of any virus in the liver."

MAVS proteins project from tiny structures called mitochondria, which are found in large numbers in each liver cell. When specialized receptor molecules detect viruses in the cell, they dock with the MAVS proteins, thereby triggering a sequence of signals ending with the production of interferon beta?a potent
'"/>

Source:University of Texas Medical Branch at Galveston


Page: 1 2

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
Post Your Comments:
(Date:12/3/2009)... ever felt overly upset by a social snubbing? Your genetics, ... long known that opium-like painkillers, called opioids, relieve not only ... a new study reviewed by Faculty of 1000 Biology member ... for the opioid receptor can determine the intensity of people,s ...
(Date:12/3/2009)... of scientists from the U.S. Department of Energy,s (DOE) ... of Science has made a major step in understanding ... is necessary to carry out important biological processes. The ... Nature Structural & Molecular Biology , confirms that ...
(Date:12/2/2009)... results strengthen the evidence that people who smoke cigarettes ... risk for developing colorectal cancer, even after adjusting for ... reason not to smoke, or to quit as soon ... M.S., vice president emeritus, epidemiology and surveillance research at ...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Cigarette smoking increases colorectal cancer risk 2CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 1CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 2CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 3Lab on a Chip Might Speed Breast Cancer Monitoring 59092 1Lab on a Chip Might Speed Breast Cancer Monitoring 59092 2Lab on a Chip Might Speed Breast Cancer Monitoring 59092 3DOE Labs Take Pride in Award Winning IBM Blue Gene Series 14388 1DOE Labs Take Pride in Award Winning IBM Blue Gene Series 14388 2DOE Labs Take Pride in Award Winning IBM Blue Gene Series 14388 3DOE Labs Take Pride in Award Winning IBM Blue Gene Series 14388 4
... ones in head-to-head mating contests but,diminutive males make ... and faster on their feet, a new study ... online issue of Journal of Evolutionary,Biology , ... defining,mating and paternity success. In field enclosures, researchers,simulated ...
... the Katholieke Universiteit Leuven have discovered an important new mechanism ... same way − and with the same effects as ... can teach us more about how food affects our body; ... targets for medicines. , Receptors , Every ...
... Quantum dots, tiny luminescent particles made of semiconductors, ... However, if doctors were to use them in ... their size and possible toxicity. , Scientists at ... have found a way around those limitations by ...
Other Biology News:Spider love: Little guys get lots more 2Food can affect a cell in the same way hormones do 2'Strained' quantum dots show new optical properties 2
(Date:12/3/2009)... ACCESS PHARMACEUTICALS, INC. (OTC Bulletin ... commercial launch of MuGard, an FDA approved treatment for ... and chemotherapy. MuGard is commercially launched by Access, partner, ... Italy, Norway, Greece and Sweden. Access is conducting pre-marketing ...
(Date:12/3/2009)... Inverness Medical Innovations, Inc. (NYSE: IMA ), ... their health at home through the merger of rapid diagnostics ... share on its Series B Convertible Perpetual Preferred Stock ( ... B stock in an amount per share equal to the ...
(Date:12/2/2009)... Spectrum Blue Steel is emerging as one of the ... efforts of True Green Energy Group and True Green Planet,s ... the recycling business for over 25 years, stated that Spectrum ... setting the stage for spectacular earnings because of the bi ...
(Date:12/2/2009)... YORK, Dec. 2 Nearly 600 medical research executives, ... novel development approaches and innovative funding strategies at the ... FasterCures, the Washington-based center of the Milken ... multi-sector collaborations needed to turn a scientific discovery into ...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
... Spherix Incorporated (Nasdaq: SPEX ), an innovator in ... food, supplement, biotechnology and pharmaceutical companies, today reported results for the ... , ... Naturlose(R) Phase 3 clinical trial investigating efficacy as ...
... Innovations, Inc. (NYSE: IMA ), a global leader ... home through the merger of rapid diagnostics and health management, ... Series B Convertible Perpetual Preferred Stock (NYSE: IMA-PB). The dividend ... an amount per share equal to the quotient of (a) ...
... 2009 Senomyx, Inc. (Nasdaq: SNMX ), ... discover and develop novel flavor ingredients for the food, ... of the collaborative research phase under its initial collaborative ... global manufacturer and marketer of high quality soup and ...
Other Biology Technology:Spherix Announces 2008 Financial Results 2Spherix Announces 2008 Financial Results 3Spherix Announces 2008 Financial Results 4Spherix Announces 2008 Financial Results 5Spherix Announces 2008 Financial Results 6Spherix Announces 2008 Financial Results 7Spherix Announces 2008 Financial Results 8SENOMYX ANNOUNCES EXTENSION OF ITS COLLABORATION WITH CAMPBELL SOUP COMPANY 2SENOMYX ANNOUNCES EXTENSION OF ITS COLLABORATION WITH CAMPBELL SOUP COMPANY 3
Polyclonal Antibody to Golgin-67...
Polyclonal Antibody to AHI1 / Jouberin...
Request Info...
Peptide-affinity Purified Polyclonal Antibody to SMAD7 Peptide with sequence SSCPCWLEVIFNSR, from C Terminus of the protein sequence according to NP_005895....
Biology Products: